It plays a central role in: Boosting insulin and reducing glucagon, which helps stabilise blood sugar Slowing gastric emptying , so food stays in your stomach longer Promoting satiety , the feeling of being full and satisfied This is why GLP-1 is a major focus in both obesity and type 2 diabetes care, and why medications that mimic it have become so widely used
We dont prescribe stacks based on trends we prescribe them based on your lab results
Understanding the science behind oral delivery Peptide-based therapies face major challenges due to gastrointestinal degradation and limited absorption
Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma
Experts say research is ongoing to test orforglipron for weight loss in people without diabetes and to confirm its safety profile an important step, not least as Pfizer recently ditched its small molecule GLP-1 drug over a potential drug-induced liver injury
Semaglutide: This medication mimics a natural hormone, helping to control your appetite and manage blood sugar
